{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T06:43:39Z","timestamp":1775889819098,"version":"3.50.1"},"reference-count":31,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Septic arthritis is routinely treated with joint drainage and antibiotics; however, adjunctive systemic corticosteroids may improve outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>To (1) describe variation in intravenous dexamethasone use and (2) evaluate the association of intravenous dexamethasone use with outcomes among children hospitalized with septic arthritis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>This is a retrospective cohort study of hospitalized children using the Pediatric Health Information System database. We identified intravenous dexamethasone use (on hospital days 0\u20132) in children with an International Classification of Diseases, Tenth Revision discharge code for septic arthritis (M00.x). The primary outcome was hospital length of stay (LOS). Secondary outcomes included costs, postdrainage imaging, opioid use, repeat drainage procedures, and 30-day emergency department or hospital revisits. We used propensity score matching to account for measured differences between dexamethasone recipients and nonrecipients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>We identified 3524 hospitalizations across 47 hospitals from 2016 to 2020. The median rate of dexamethasone use across hospitals was 28% (IQR, 19%\u201344%). In the propensity-matched cohort, dexamethasone was associated with shorter LOS (100.5 vs 114.3\u00a0hours, P\u2009&amp;lt;\u2009.001) and lower costs ($16\u2009660 vs $18\u2009243, P\u2009=\u2009.01) but greater opioid use (odds ratio [OR], 3.80; 95% CI, 1.49\u20139.70; P\u2009&amp;lt;\u2009.01). There were no significant differences in 30-day revisits (OR, 0.97; 95% CI, 0.73\u20131.29; P\u2009=\u2009.84), postdrainage computed tomography or magnetic resonance imaging (OR, 0.91; 95% CI, 0.71\u20131.15; P\u2009=\u2009.42), or repeat drainage procedures (OR, 1.01; 95% CI, 0.81\u20131.25; P\u2009=\u2009.94).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSION<\/jats:title>\n                  <jats:p>In this large cohort study, children with septic arthritis receiving dexamethasone had shorter hospital LOS and costs without higher 30-day revisit rates. Dexamethasone use varied widely across hospitals. These findings highlight the need for evaluation in a multicenter randomized trial.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2024-008047","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T20:02:26Z","timestamp":1743969746000},"page":"369-377","source":"Crossref","is-referenced-by-count":2,"title":["Intravenous Dexamethasone Use and Outcomes in Children Hospitalized With Septic Arthritis"],"prefix":"10.1542","volume":"15","author":[{"given":"Andrew S.","family":"Kern-Goldberger","sequence":"first","affiliation":[{"name":"1Division of Pediatric Hospital Medicine, Cleveland Clinic Children\u2019s Hospital and Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Hall","sequence":"additional","affiliation":[{"name":"2Children\u2019s Hospital Association, Lenexa, Kansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Mestre","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, Nicklaus Children\u2019s Hospital, Miami, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L.","family":"Markham","sequence":"additional","affiliation":[{"name":"4Department of Pediatrics, Children\u2019s Mercy Kansas City and University of Missouri Kansas City, Kansas City, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie E.","family":"Wang","sequence":"additional","affiliation":[{"name":"5Department of Pediatrics, Stanford University School of Medicine and Lucile Packard Children\u2019s Hospital Stanford, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratichi K.","family":"Goenka","sequence":"additional","affiliation":[{"name":"6Department of Pediatrics, Cohen Children\u2019s Medical Center-Northwell Health and Zucker School of Medicine at Hofstra\/Northwell, Hofstra University, New Hyde Park, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura H.","family":"Brower","sequence":"additional","affiliation":[{"name":"7Department of Pediatrics, Cincinnati Children\u2019s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Payson","sequence":"additional","affiliation":[{"name":"6Department of Pediatrics, Cohen Children\u2019s Medical Center-Northwell Health and Zucker School of Medicine at Hofstra\/Northwell, Hofstra University, New Hyde Park, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Villani","sequence":"additional","affiliation":[{"name":"8Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Rice Denning","sequence":"additional","affiliation":[{"name":"9Division of Orthopedics, Cincinnati Children\u2019s Hospital Medical Center and the University of Cincinnati Department of Orthopedic Surgery, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir S.","family":"Shah","sequence":"additional","affiliation":[{"name":"7Department of Pediatrics, Cincinnati Children\u2019s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"issue":"11","key":"2025072210024162200_r1","first-page":"CD012125","article-title":"Corticosteroids for septic arthritis in children","volume":"11","author":"Delgado-Noguera","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"2025072210024162200_r2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/PHMT.S115429","article-title":"Septic arthritis in children: diagnosis and treatment","volume":"8","author":"P\u00e4\u00e4kk\u00f6nen","year":"2017","journal-title":"Pediatric Health Med Ther."},{"issue":"7","key":"2025072210024162200_r3","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2106\/00004623-198769070-00015","article-title":"The effect of antibiotics on the destruction of cartilage in experimental infectious arthritis","volume":"69","author":"Smith","year":"1987","journal-title":"J Bone Joint Surg Am."},{"issue":"3","key":"2025072210024162200_r4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1442-200X.2008.02791.x","article-title":"Acute septic arthritis in children","volume":"51","author":"Al Saadi","year":"2009","journal-title":"Pediatr Int."},{"key":"2025072210024162200_r5","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2147\/DDDT.S163560","article-title":"Corticosteroids as adjunctive therapy with antibiotics in the treatment of children with septic arthritis: a meta-analysis","volume":"12","author":"Qin","year":"2018","journal-title":"Drug Des Devel Ther."},{"issue":"7","key":"2025072210024162200_r6","first-page":"463","article-title":"Late sequelae of hip septic arthritis in children","volume":"50","author":"Baghdadi","year":"2012","journal-title":"Acta Med Iran."},{"issue":"1","key":"2025072210024162200_r7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12891-015-0702-3","article-title":"A systematic review and meta-analysis regarding the use of corticosteroids in septic arthritis","volume":"16","author":"Farrow","year":"2015","journal-title":"BMC Musculoskelet Disord."},{"issue":"5","key":"2025072210024162200_r8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00167-020-05978-7","article-title":"Why do we not prescribe steroids in acute native septic arthritis?","volume":"28","author":"Donell","year":"2020","journal-title":"Knee Surg Sports Traumatol Arthrosc."},{"issue":"1","key":"2025072210024162200_r9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jpids\/piad089","article-title":"Clinical Practice Guideline by the Pediatric Infectious Diseases Society (PIDS) and the Infectious Diseases Society of America (IDSA): 2023 Guideline on Diagnosis and Management of Acute Bacterial Arthritis in Pediatrics","volume":"13","author":"Woods","year":"2024","journal-title":"J Pediatric Infect Dis Soc."},{"issue":"5","key":"2025072210024162200_r10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/pch\/pxy049","article-title":"Diagnosis and management of acute osteoarticular infections in children","volume":"23","author":"Le Saux","year":"2018","journal-title":"Paediatr Child Health."},{"issue":"2","key":"2025072210024162200_r11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.12788\/jhm.3538","article-title":"Opportunities for stewardship in the transition from intravenous to enteral antibiotics in hospitalized pediatric patients","volume":"16","author":"Cotter","year":"2021","journal-title":"J Hosp Med."},{"issue":"3","key":"2025072210024162200_r12","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1097\/BPO.0000000000002337","article-title":"Seasonal variation of pediatric septic arthritis in the United States: A PHIS Database Study","volume":"43","author":"Patankar","year":"2023","journal-title":"J Pediatr Orthop."},{"issue":"1","key":"2025072210024162200_r13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2431-14-199","article-title":"Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation","volume":"14","author":"Feudtner","year":"2014","journal-title":"BMC Pediatr."},{"issue":"2","key":"2025072210024162200_r14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1542\/hpeds.2022-006821","article-title":"Using administrative billing codes to identify acute musculoskeletal infections in children","volume":"13","author":"Searns","year":"2023","journal-title":"Hosp Pediatr."},{"issue":"10","key":"2025072210024162200_r15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.inf.0000091293.32187.7b","article-title":"Double blind, randomized, placebo-controlled study of dexamethasone therapy for hematogenous septic arthritis in children","volume":"22","author":"Odio","year":"2003","journal-title":"Pediatr Infect Dis J."},{"issue":"2","key":"2025072210024162200_r16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/BPO.0b013e3182092869","article-title":"Dexamethasone therapy for septic arthritis in children: results of a randomized double-blind placebo-controlled study","volume":"31","author":"Harel","year":"2011","journal-title":"J Pediatr Orthop."},{"issue":"1","key":"2025072210024162200_r17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/MOP.0b013e32835c2b42","article-title":"Osteomyelitis and septic arthritis in children: current concepts","volume":"25","author":"Dodwell","year":"2013","journal-title":"Curr Opin Pediatr."},{"issue":"3","key":"2025072210024162200_r18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.berh.2011.02.001","article-title":"Septic arthritis","volume":"25","author":"Garc\u00eda-Arias","year":"2011","journal-title":"Best Pract Res Clin Rheumatol."},{"issue":"5","key":"2025072210024162200_r19","first-page":"955","article-title":"The effect of intravenous dexamethasone in the treatment of septic arthritis","volume":"30","author":"Arti","year":"2014","journal-title":"Pak J Med Sci."},{"issue":"4","key":"2025072210024162200_r20","doi-asserted-by":"crossref","first-page":"e776","DOI":"10.1542\/peds.2014-4025","article-title":"Dexamethasone therapy for septic arthritis in children","volume":"136","author":"Fogel","year":"2015","journal-title":"Pediatrics."},{"issue":"1","key":"2025072210024162200_r21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13054-021-03717-z","article-title":"Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients","volume":"25","author":"Kooistra","year":"2021","journal-title":"Crit Care."},{"issue":"6","key":"2025072210024162200_r22","first-page":"358","article-title":"Drugs and appetite: an overview of appetite stimulants in the pediatric patient","volume":"2","author":"Gura","year":"2010","journal-title":"ICAN: Infant, Child, & Adolescent Nutrition."},{"issue":"5","key":"2025072210024162200_r23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/adc.2003.041541","article-title":"Adverse psychological effects of corticosteroids in children and adolescents","volume":"90","author":"Stuart","year":"2005","journal-title":"Arch Dis Child."},{"issue":"4","key":"2025072210024162200_r24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/archdischild-2015-309522","article-title":"Systematic review of the toxicity of short-course oral corticosteroids in children","volume":"101","author":"Aljebab","year":"2016","journal-title":"Arch Dis Child."},{"issue":"7","key":"2025072210024162200_r25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/jamapediatrics.2021.0433","article-title":"Association of oral corticosteroid bursts with severe adverse events in children","volume":"175","author":"Yao","year":"2021","journal-title":"JAMA Pediatr."},{"issue":"1","key":"2025072210024162200_r26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1542\/hpeds.2021-005910","article-title":"Association between corticosteroids and outcomes in children hospitalized with orbital cellulitis","volume":"12","author":"Gill","year":"2022","journal-title":"Hosp Pediatr."},{"issue":"5","key":"2025072210024162200_r27","doi-asserted-by":"crossref","first-page":"e2020037010","DOI":"10.1542\/peds.2020-037010","article-title":"Corticosteroids in the treatment of pediatric retropharyngeal and parapharyngeal abscesses","volume":"148","author":"Goenka","year":"2021","journal-title":"Pediatrics."},{"issue":"5","key":"2025072210024162200_r28","doi-asserted-by":"crossref","first-page":"e2021050677","DOI":"10.1542\/peds.2021-050677","article-title":"Corticosteroids for acute orbital cellulitis","volume":"148","author":"Leszczynska","year":"2021","journal-title":"Pediatrics."},{"issue":"1","key":"2025072210024162200_r29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1542\/hpeds.2017-0040","article-title":"Variation in care and clinical outcomes in children hospitalized with orbital cellulitis","volume":"8","author":"Markham","year":"2018","journal-title":"Hosp Pediatr."},{"issue":"9","key":"2025072210024162200_r30","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1542\/hpeds.2022-006691","article-title":"A pediatric hospital medicine primer for performing research using administrative data","volume":"12","author":"Markham","year":"2022","journal-title":"Hosp Pediatr."},{"issue":"2","key":"2025072210024162200_r31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1542\/hpeds.2019-0218","article-title":"Distinguishing children\u2019s hospitals from non-children\u2019s hospitals in large claims data","volume":"10","author":"Piper","year":"2020","journal-title":"Hosp Pediatr."}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/15\/5\/369\/1797158\/hosppeds.2024008047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/15\/5\/369\/1797158\/hosppeds.2024008047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T14:19:53Z","timestamp":1753193993000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/15\/5\/369\/201555\/Intravenous-Dexamethasone-Use-and-Outcomes-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,4,7]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2024-008047","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]}}}